HealthEquity: HSA Momentum Meets the Interchange Question Nobody Wants to Answer
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
HealthEquity reports before market open, meaning Day 0 captures the first full trading session reaction to results, while Day +1 reflects follow-through or reversal.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-05-28 | +$3.96 (+4.57%) | $5.32 (6.15%) | -$2.53 (-2.79%) | $8.95 (9.89%) |
| 2026-03-17 | +$0.73 (+0.93%) | $1.98 (2.52%) | +$0.17 (+0.21%) | $5.65 (7.11%) |
| 2025-12-03 | -$0.24 (-0.24%) | $3.37 (3.41%) | -$2.97 (-3.01%) | $9.28 (9.41%) |
| 2025-09-02 | -$0.48 (-0.54%) | $2.27 (2.54%) | +$6.69 (+7.53%) | $4.95 (5.57%) |
| 2025-06-03 | +$0.95 (+0.92%) | $3.63 (3.53%) | +$9.30 (+8.96%) | $8.24 (7.94%) |
| 2025-03-18 | +$0.95 (+0.94%) | $3.30 (3.27%) | -$17.35 (-17.07%) | $7.07 (6.95%) |
| 2024-12-09 | +$0.79 (+0.79%) | $2.63 (2.63%) | -$5.61 (-5.55%) | $8.12 (8.04%) |
| 2024-09-03 | -$0.93 (-1.17%) | $2.51 (3.15%) | +$4.03 (+5.13%) | $9.66 (12.28%) |
| Avg Abs Move | 1.26% | 3.40% | 6.28% | 8.40% |
Historical price action shows moderate Day 0 volatility averaging 1.26% absolute movement, with an intraday range averaging 3.40%. The real action typically comes on Day +1, where the stock has moved an average of 6.28% with intraday swings averaging 8.40%—suggesting initial reactions are often reassessed as investors digest the details.
The most recent earnings (May 2026) illustrates this pattern: the stock jumped 4.57% on Day 0 following a strong beat, then reversed 2.79% on Day +1 as profit-taking set in. The largest move in the dataset came in March 2025, when the stock plunged 17.07% on Day +1 despite a modest Day 0 gain, highlighting how guidance or commentary can override the initial EPS reaction. Conversely, June 2025 and September 2025 both saw strong Day +1 rallies of 8.96% and 7.53% respectively, demonstrating the stock's capacity for sustained post-earnings momentum when results and outlook align.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 09/18/26 (DTE 23) |
| Expected Move | $8.26 (7.91%) |
| Expected Range | $96.16 to $112.68 |
| Implied Volatility | 48.87% |
The options market is pricing an expected move of 7.91% through the September 18 expiration, which sits between the historical Day 0 average of 1.26% and the Day +1 average of 6.28%, but below the combined two-day average absolute move that has characterized recent reports. This suggests options traders may be underpricing potential volatility, particularly if the pattern of delayed Day +1 reactions holds.
Part 3: What Analysts Are Saying
Analyst sentiment on HealthEquity is overwhelmingly bullish, with the stock carrying an average recommendation of 4.59 out of 5.00—firmly in Strong Buy territory. The consensus breakdown shows 14 Strong Buys, 1 Moderate Buy, 1 Hold, and 1 Strong Sell among 17 analysts covering the stock.
The mean price target of $116.06 implies 11.1% upside from the current price of $104.42, with estimates ranging from a low of $89.00 to a high of $135.00. The wide range reflects differing views on valuation and growth sustainability, but the clustering of ratings at the bullish end indicates broad conviction in the company's trajectory.
Sentiment has remained unchanged over the past month, with ratings counts and the average recommendation holding steady at 4.59. This stability suggests analysts are comfortable with their bullish stance heading into the print and are not rushing to adjust views ahead of results. The lack of recent downgrades or estimate cuts indicates confidence that the company will deliver in line with or above expectations, consistent with its recent track record.
Part 4: Technical Picture
HealthEquity's technical setup heading into earnings reflects strong momentum and broad-based buying pressure. The Barchart Technical Opinion currently stands at 100% Buy, unchanged from last week but improved from 88% Buy a month ago, signaling strengthening conviction among technical indicators.
Timeframe Analysis:
- Short-term (100% Buy): Maximum bullish signal indicates powerful near-term momentum as the stock approaches earnings
- Medium-term (100% Buy): Sustained buy signal confirms the intermediate trend remains firmly positive
- Long-term (100% Buy): Strong long-term buy reading suggests the broader uptrend is intact and well-supported
Trend Characteristics: The combination of Maximum strength and Average direction indicates a powerful but measured uptrend—momentum is robust without showing signs of overextension or exhaustion.
The stock is trading at $104.42, positioned above its 20-day ($104.28), 50-day ($97.60), 100-day ($91.06), and 200-day ($89.48) moving averages but below its 5-day ($104.98) and 10-day ($104.43) moving averages. This configuration shows a strong longer-term uptrend with minor near-term consolidation just beneath recent highs.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $104.98 | 50-Day MA | $97.60 |
| 10-Day MA | $104.43 | 100-Day MA | $91.06 |
| 20-Day MA | $104.28 | 200-Day MA | $89.48 |
The stock sits just $3.20 below its 52-week high of $107.62, suggesting limited overhead resistance if earnings catalyze a breakout. The rising 50-day and 200-day moving averages provide technical support in the $97-$89 zone, offering a cushion if results disappoint. Overall, the technical setup is supportive for earnings, with momentum indicators aligned bullishly and the stock well-positioned above key moving averages. However, the proximity to 52-week highs means the bar for a positive surprise may be elevated—any guidance disappointment could trigger profit-taking from an extended technical position.